The Impact of Expandable Cryoballoon on Autonomic Control of the Heart

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

Also called NCT06053606

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06053606
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06053606. Randomized; single masking; primary purpose treatment. Start 2024-05-10 (actual); primary completion 2027-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of Expandable Cryoballoon on Autonomic Control of the Heart
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
cryoablation of atrial fibrillation using only 28 mm size balloon
Intervention (Device)
cryoablation of atrial fibrillation using expandable balloon (28 / 31 mm)
Lead sponsor
Wroclaw Medical University (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct06053606
Content hash
b548ad2ac72f83ee32150b47c2f0b816b26d203be32d7bfde783b99179e839d7